Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
about
The genetic epidemiology of neurodegenerative disease.A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New GuineaGenetic susceptibility, evolution and the kuru epidemicA novel human disease with abnormal prion protein sensitive to proteaseKuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type miceUpdated projections of future vCJD deaths in the UKvCJD risk in the Republic of IrelandPrion diseases: immunotargets and therapyAn overview of human prion diseasesCrystal structure of human prion protein bound to a therapeutic antibodySporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1.Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNPHuman prion diseases: surgical lessons learned from iatrogenic prion transmissionIs the prevalent human prion protein 129M/V mutation a living fossil from a Paleolithic panzootic superprion pandemic?Mammalian prions: tolerance to sequence changes-how far?Selenomethionine incorporation into amyloid sequences regulates fibrillogenesis and toxicityDetermination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by 1H NMR and restrained molecular dynamics.Rationale for diagnosing human prion disease.Creutzfeldt-Jakob disease risk and PRNP codon 129 polymorphism: necessity to revalue current data.Dissecting trait heterogeneity: a comparison of three clustering methods applied to genotypic dataCreutzfeldt-Jakob disease segregating in a three generation Danish family.HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.Neurodegeneration in humans caused by prionsClinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case.Genetic studies in human prion diseases.Epidemiological mechanisms of genetic resistance to kuru.The retinoic acid receptor beta (Rarb) region of Mmu14 is associated with prion disease incubation time in mouse.Dietary Risk Factors for Sporadic Creutzfeldt-Jakob Disease: A Confirmatory Case-Control Study.Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteinsCreutzfeldt-Jakob disease and haemophilia: assessment of risk.Lack of prion transmission by sexual or parental routes in experimentally infected hamstersCreutzfeldt-Jakob disease and the eye. I. Background and patient management.Kuru: genes, cannibals and neuropathology.Familial conformational diseases and dementias.Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.Clinical implications of bovine spongiform encephalopathy.Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians.Molecular pathology of human prion disease.
P2860
Q22306301-507C4847-1556-4A49-88E8-4565BF2F34EEQ24642582-2D0D4547-4D0D-461B-B40E-7EEB0DC00320Q24645692-D2B63799-3D36-4D9D-B5EE-734E5B9449A0Q24648865-8FA87114-F3D0-47D4-8B45-03630BE0D500Q24651920-992230C3-D879-4A8F-8473-F352CB43999BQ24799671-65070B8D-DCCE-4CA1-BC37-44D73865456CQ24801647-4CEEEF95-941B-4DCF-A74B-269582102B99Q26741258-6EBEC13E-B9F7-4CEE-A531-038C1A6B67ADQ27007967-8E838CE9-1EF7-42D7-973C-B9C913CFFD04Q27653698-1BDFDE65-312C-4BD8-9ADA-24E652962D98Q28363814-20EC903A-FA72-4470-AB3D-2712F0CFED21Q28943533-A59A1B43-9D7F-4C31-BED9-2B1BDD36546BQ30249207-0516DDCC-8AB6-45AC-92F1-5372C5E127EFQ30357614-3938E072-8140-4019-BFC9-64404CD627EEQ30424667-F9B85D2C-5C34-473F-802F-DC5771A384B7Q30472712-6C33D80B-AB33-4F1E-B173-489C350CC726Q30585001-8A58FB0C-8080-461B-A39B-8FFF1606426FQ30936688-C28992B4-778A-4E22-B750-2FD1E322EEBBQ31022908-356E6E66-DA8C-4F2A-95FD-A2FE31B008E3Q31036518-F294FD12-A6BB-425D-93BA-6E45AE2422DEQ32153658-645A7086-CAFD-4591-9C26-E7D32FD6E165Q33503386-06F20939-776C-429A-BC9E-FF48F9115915Q33582070-18CC4FEE-68AE-4419-88F4-100FD8E9D87DQ33591914-7A6BB3FB-8942-4824-83FB-FEA341A6DD2EQ33592086-3A725DF7-01AE-44F3-ABD6-03794A095DDFQ33627593-ABD25530-3678-405B-843D-3B802C68DFAFQ33704994-5B06C6F0-66E3-45DA-AA0F-C24D7B39C07EQ33769410-89040449-1C28-4A4A-90F4-7EE3F339E371Q33805341-C40418EF-2600-4791-A996-BADC7365F18FQ33816387-C9468A02-C6D0-4706-8114-23A5D932BA04Q33910752-A869EDAD-35F8-415C-A25B-CFFF64D98677Q34029494-863DFC33-BA24-48BF-AA26-8A356F9032BBQ34051195-4BA13B9E-C141-4908-BB3B-D6134EA56CBCQ34057654-F764B68A-E87B-4DAF-8B6E-CFA36C62E1B9Q34128933-6949E705-0D8F-4C9C-9E1D-3CCED99B8576Q34138249-21276161-327D-49AB-8782-5787117BC0FDQ34153674-85D6778D-45D7-4CFB-82FD-CC581BE37330Q34255643-F2090E80-F101-412B-BCA6-40866A3FA396Q34271938-2C3E5D7E-8451-4DD3-82FF-EDAD8F0F23F5Q34462913-6208BB2F-92CF-4C76-BB9C-199A854EC28D
P2860
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
@en
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
@nl
type
label
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
@en
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
@nl
prefLabel
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
@en
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
@nl
P2093
P1433
P1476
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
@en
P2093
A J Dryden
J Collinge
M S Palmer
P304
P356
10.1016/0140-6736(91)93128-V
P407
P577
1991-06-01T00:00:00Z